Medications ›nandrolone decanoate

nandrolone decanoate

RxCUI 31494 precise ingredient

Contraindicated with · 27

Diagnoses8

Nephrosis Genital Neoplasms, Male Infant Age Groups Genital Diseases, Male Pregnancy Reproduction Drug Hypersensitivity

Condition families19

Prostatic Neoplasms Prostatic Diseases Breast Neoplasms Breast Diseases Urogenital Neoplasms Genital Diseases Kidney Diseases Neoplasms by Site Reproductive Physiological Phenomena Urologic Diseases Neoplasms Male Urogenital Diseases Female Urogenital Diseases Skin Diseases Female Urogenital Diseases and Pregnancy Complications Skin and Connective Tissue Diseases Urogenital Diseases Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 9

Diagnoses1

Anemia

Condition families8

Breast Neoplasms Breast Diseases Neoplasms by Site Hematologic Diseases Hemic and Lymphatic Diseases Neoplasms Skin Diseases Skin and Connective Tissue Diseases

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.